Related Experiment Video
Updated: Jun 20, 2026

Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
Identification of Coronavirus Isolated from a Patient in Korea with COVID-19
Jeong-Min Kim1, Yoon-Seok Chung1, Hye Jun Jo1
1Division of Viral Diseases, Center for Laboratory Control of Infectious Diseases, Korea Centers for Disease Control and Prevention, Cheongju, Korea.
Insights
Researchers successfully isolated SARS-CoV-2, the virus causing COVID-19, from patients in South Korea. This isolation aids in understanding and combating the novel coronavirus pandemic.
Area of Science:
- Virology
- Infectious Diseases
- Public Health
Background:
- The emergence of coronavirus disease 2019 (COVID-19) in Wuhan, China, led to global health concerns.
- The causative agent, SARS-CoV-2, was identified, prompting efforts to isolate the virus from affected individuals worldwide.
Purpose of the Study:
- To isolate and identify the SARS-CoV-2 virus from patients in South Korea presenting with pneumonia.
- To characterize the isolated virus through genomic sequencing and electron microscopy.
Main Methods:
- Respiratory samples from suspected COVID-19 patients were used for virus isolation in cell cultures.
- Full genome sequencing was performed to determine viral genetic relatedness.
- Electron microscopy was employed to visualize viral morphology.
Main Results:
- The virus replicated successfully in Vero cells, showing cytopathic effects.
- Genomic sequencing confirmed the isolated virus as SARS-CoV-2, with over 99.9% homology to strains from China.
- Electron microscopy revealed characteristic coronavirus morphology.
Conclusions:
- SARS-CoV-2 was successfully isolated from South Korean patients with COVID-19 symptoms.
- The isolated strain, BetaCoV/Korea/KCDC03/2020, is genetically similar to other SARS-CoV-2 isolates.
- This isolation is crucial for further research and development of diagnostic and therapeutic strategies.
Objectives:
Following reports of patients with unexplained pneumonia at the end of December 2019 in Wuhan, China, the causative agent was identified as coronavirus (SARS-CoV-2), and the 2019 novel coronavirus disease was named COVID-19 by the World Health Organization. Putative patients with COVID-19 have been identified in South Korea, and attempts have been made to isolate the pathogen from these patients.
Methods:
Upper and lower respiratory tract secretion samples from putative patients with COVID-19 were inoculated onto cells to isolate the virus. Full genome sequencing and electron microscopy were used to identify the virus.
Results:
The virus replicated in Vero cells and cytopathic effects were observed. Full genome sequencing showed that the virus genome exhibited sequence homology of more than 99.9% with SARS-CoV-2 which was isolated from patients from other countries, for instance China. Sequence homology of SARS-CoV-2 with SARS-CoV, and MERS-CoV was 77.5% and 50%, respectively. Coronavirus-specific morphology was observed by electron microscopy in virus-infected Vero cells.
Conclusion:
SARS-CoV-2 was isolated from putative patients with unexplained pneumonia and intermittent coughing and fever. The isolated virus was named BetaCoV/Korea/KCDC03/2020.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Rapid Identification of Pathogens
Coronavirus

